SOD2 and metabolic dysfunction-associated steatotic liver disease: paracasei YBJ01 has a promoting effect on the protein expression of SOD1 and SOD2 in the mice liver (Suo et al., 2018) In a high-fat-fed rat model of non-alcoholic fatty liver disease, Chen et al. (2018) found that Lactobacillus mali APS1 intervention significantly reduced MDA levels and promoted SOD activity in the liver, improving antioxidant capacity.